nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—Cerebral artery embolism—Levothyroxine—hypothyroidism	0.055	0.0752	CcSEcCtD
Pramipexole—Cerebral artery embolism—Dextrothyroxine—hypothyroidism	0.055	0.0752	CcSEcCtD
Pramipexole—Cerebral artery embolism—Liotrix—hypothyroidism	0.0404	0.0553	CcSEcCtD
Pramipexole—Choking—Dextrothyroxine—hypothyroidism	0.0251	0.0343	CcSEcCtD
Pramipexole—Choking—Levothyroxine—hypothyroidism	0.0251	0.0343	CcSEcCtD
Pramipexole—Metabolic alkalosis—Liotrix—hypothyroidism	0.0232	0.0318	CcSEcCtD
Pramipexole—Choking—Liotrix—hypothyroidism	0.0185	0.0252	CcSEcCtD
Pramipexole—Bronchopneumonia—Liotrix—hypothyroidism	0.0154	0.0211	CcSEcCtD
Pramipexole—HTR2A—cerebellar cortex—hypothyroidism	0.0121	0.0879	CbGeAlD
Pramipexole—Pharyngeal oedema—Liotrix—hypothyroidism	0.0118	0.0161	CcSEcCtD
Pramipexole—Hyperthyroidism—Dextrothyroxine—hypothyroidism	0.0116	0.0159	CcSEcCtD
Pramipexole—Hyperthyroidism—Levothyroxine—hypothyroidism	0.0116	0.0159	CcSEcCtD
Pramipexole—DRD1—nerve—hypothyroidism	0.0113	0.0827	CbGeAlD
Pramipexole—Muscle twitching—Liothyronine—hypothyroidism	0.0095	0.013	CcSEcCtD
Pramipexole—Hyperthyroidism—Liotrix—hypothyroidism	0.00853	0.0117	CcSEcCtD
Pramipexole—DRD4—heart—hypothyroidism	0.00837	0.061	CbGeAlD
Pramipexole—Phlebitis—Liothyronine—hypothyroidism	0.00786	0.0108	CcSEcCtD
Pramipexole—Cardiac failure congestive—Liothyronine—hypothyroidism	0.00747	0.0102	CcSEcCtD
Pramipexole—DRD2—nerve—hypothyroidism	0.0067	0.0488	CbGeAlD
Pramipexole—HTR2A—urine—hypothyroidism	0.00641	0.0467	CbGeAlD
Pramipexole—Angina pectoris—Liothyronine—hypothyroidism	0.0057	0.0078	CcSEcCtD
Pramipexole—DRD4—testis—hypothyroidism	0.00516	0.0376	CbGeAlD
Pramipexole—Acute coronary syndrome—Liothyronine—hypothyroidism	0.00514	0.00704	CcSEcCtD
Pramipexole—Myocardial infarction—Liothyronine—hypothyroidism	0.00512	0.007	CcSEcCtD
Pramipexole—Intestinal obstruction—Liotrix—hypothyroidism	0.00494	0.00676	CcSEcCtD
Pramipexole—Cyanosis—Liotrix—hypothyroidism	0.00476	0.00651	CcSEcCtD
Pramipexole—Wheezing—Dextrothyroxine—hypothyroidism	0.00445	0.00609	CcSEcCtD
Pramipexole—Wheezing—Levothyroxine—hypothyroidism	0.00445	0.00609	CcSEcCtD
Pramipexole—HTR2A—nerve—hypothyroidism	0.00442	0.0322	CbGeAlD
Pramipexole—Feeling hot—Liotrix—hypothyroidism	0.00429	0.00587	CcSEcCtD
Pramipexole—Abscess—Liotrix—hypothyroidism	0.00426	0.00583	CcSEcCtD
Pramipexole—Coma—Dextrothyroxine—hypothyroidism	0.00419	0.00573	CcSEcCtD
Pramipexole—Coma—Levothyroxine—hypothyroidism	0.00419	0.00573	CcSEcCtD
Pramipexole—Hyperkinesia—Levothyroxine—hypothyroidism	0.004	0.00547	CcSEcCtD
Pramipexole—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.004	0.00547	CcSEcCtD
Pramipexole—DRD5—female gonad—hypothyroidism	0.00384	0.028	CbGeAlD
Pramipexole—Disorientation—Dextrothyroxine—hypothyroidism	0.00372	0.00508	CcSEcCtD
Pramipexole—Disorientation—Levothyroxine—hypothyroidism	0.00372	0.00508	CcSEcCtD
Pramipexole—Cellulitis—Liotrix—hypothyroidism	0.00371	0.00507	CcSEcCtD
Pramipexole—Hypocalcaemia—Liotrix—hypothyroidism	0.00368	0.00503	CcSEcCtD
Pramipexole—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.00367	0.00502	CcSEcCtD
Pramipexole—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.00367	0.00502	CcSEcCtD
Pramipexole—Oliguria—Liotrix—hypothyroidism	0.00366	0.005	CcSEcCtD
Pramipexole—Increased appetite—Dextrothyroxine—hypothyroidism	0.00354	0.00484	CcSEcCtD
Pramipexole—Increased appetite—Levothyroxine—hypothyroidism	0.00354	0.00484	CcSEcCtD
Pramipexole—Hypertension—Liothyronine—hypothyroidism	0.00352	0.00482	CcSEcCtD
Pramipexole—Muscle twitching—Liotrix—hypothyroidism	0.00343	0.00469	CcSEcCtD
Pramipexole—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00341	0.00466	CcSEcCtD
Pramipexole—Cardiac failure—Dextrothyroxine—hypothyroidism	0.00341	0.00466	CcSEcCtD
Pramipexole—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00341	0.00466	CcSEcCtD
Pramipexole—Cardiac failure—Levothyroxine—hypothyroidism	0.00341	0.00466	CcSEcCtD
Pramipexole—Affect lability—Dextrothyroxine—hypothyroidism	0.00327	0.00448	CcSEcCtD
Pramipexole—Affect lability—Levothyroxine—hypothyroidism	0.00327	0.00448	CcSEcCtD
Pramipexole—Wheezing—Liotrix—hypothyroidism	0.00327	0.00448	CcSEcCtD
Pramipexole—Tachycardia—Liothyronine—hypothyroidism	0.00325	0.00444	CcSEcCtD
Pramipexole—HTR1B—cardiovascular system—hypothyroidism	0.00322	0.0235	CbGeAlD
Pramipexole—Fluid retention—Liotrix—hypothyroidism	0.0032	0.00438	CcSEcCtD
Pramipexole—HTR2B—adrenal cortex—hypothyroidism	0.00318	0.0232	CbGeAlD
Pramipexole—Irritability—Levothyroxine—hypothyroidism	0.00317	0.00434	CcSEcCtD
Pramipexole—Irritability—Dextrothyroxine—hypothyroidism	0.00317	0.00434	CcSEcCtD
Pramipexole—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00316	0.00433	CcSEcCtD
Pramipexole—Cardiac arrest—Levothyroxine—hypothyroidism	0.00316	0.00433	CcSEcCtD
Pramipexole—Mood swings—Dextrothyroxine—hypothyroidism	0.00315	0.00431	CcSEcCtD
Pramipexole—Mood swings—Levothyroxine—hypothyroidism	0.00315	0.00431	CcSEcCtD
Pramipexole—HTR1D—cardiovascular system—hypothyroidism	0.00312	0.0227	CbGeAlD
Pramipexole—Hypotension—Liothyronine—hypothyroidism	0.00311	0.00425	CcSEcCtD
Pramipexole—Dehydration—Dextrothyroxine—hypothyroidism	0.00309	0.00423	CcSEcCtD
Pramipexole—Dehydration—Levothyroxine—hypothyroidism	0.00309	0.00423	CcSEcCtD
Pramipexole—Coma—Liotrix—hypothyroidism	0.00308	0.00421	CcSEcCtD
Pramipexole—HTR2B—heart—hypothyroidism	0.00307	0.0224	CbGeAlD
Pramipexole—Hyperkinesia—Liotrix—hypothyroidism	0.00294	0.00402	CcSEcCtD
Pramipexole—Muscular weakness—Levothyroxine—hypothyroidism	0.00293	0.00401	CcSEcCtD
Pramipexole—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00293	0.00401	CcSEcCtD
Pramipexole—Sepsis—Liotrix—hypothyroidism	0.00292	0.004	CcSEcCtD
Pramipexole—HTR2B—cardiovascular system—hypothyroidism	0.0029	0.0211	CbGeAlD
Pramipexole—Dysphagia—Dextrothyroxine—hypothyroidism	0.00287	0.00393	CcSEcCtD
Pramipexole—Dysphagia—Levothyroxine—hypothyroidism	0.00287	0.00393	CcSEcCtD
Pramipexole—Phlebitis—Liotrix—hypothyroidism	0.00284	0.00388	CcSEcCtD
Pramipexole—Angina pectoris—Levothyroxine—hypothyroidism	0.0028	0.00383	CcSEcCtD
Pramipexole—Angina pectoris—Dextrothyroxine—hypothyroidism	0.0028	0.00383	CcSEcCtD
Pramipexole—Disorientation—Liotrix—hypothyroidism	0.00273	0.00374	CcSEcCtD
Pramipexole—Cardiac failure congestive—Liotrix—hypothyroidism	0.0027	0.00369	CcSEcCtD
Pramipexole—Body temperature increased—Liothyronine—hypothyroidism	0.00263	0.0036	CcSEcCtD
Pramipexole—Increased appetite—Liotrix—hypothyroidism	0.0026	0.00356	CcSEcCtD
Pramipexole—Weight decreased—Levothyroxine—hypothyroidism	0.0026	0.00356	CcSEcCtD
Pramipexole—Weight decreased—Dextrothyroxine—hypothyroidism	0.0026	0.00356	CcSEcCtD
Pramipexole—HTR1A—cardiovascular system—hypothyroidism	0.0026	0.0189	CbGeAlD
Pramipexole—Renal impairment—Liotrix—hypothyroidism	0.00257	0.00352	CcSEcCtD
Pramipexole—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00253	0.00346	CcSEcCtD
Pramipexole—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00253	0.00346	CcSEcCtD
Pramipexole—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00251	0.00344	CcSEcCtD
Pramipexole—Myocardial infarction—Levothyroxine—hypothyroidism	0.00251	0.00344	CcSEcCtD
Pramipexole—Hypoglycaemia—Liotrix—hypothyroidism	0.00251	0.00343	CcSEcCtD
Pramipexole—Cardiac failure—Liotrix—hypothyroidism	0.00251	0.00343	CcSEcCtD
Pramipexole—ADRA2C—adrenal cortex—hypothyroidism	0.0025	0.0182	CbGeAlD
Pramipexole—SLC22A1—blood—hypothyroidism	0.00249	0.0181	CbGeAlD
Pramipexole—Sweating—Dextrothyroxine—hypothyroidism	0.00246	0.00336	CcSEcCtD
Pramipexole—Sweating—Levothyroxine—hypothyroidism	0.00246	0.00336	CcSEcCtD
Pramipexole—ADRA2C—heart—hypothyroidism	0.00242	0.0176	CbGeAlD
Pramipexole—Affect lability—Liotrix—hypothyroidism	0.00241	0.00329	CcSEcCtD
Pramipexole—Irritability—Liotrix—hypothyroidism	0.00233	0.00319	CcSEcCtD
Pramipexole—Cardiac arrest—Liotrix—hypothyroidism	0.00233	0.00318	CcSEcCtD
Pramipexole—Mood swings—Liotrix—hypothyroidism	0.00232	0.00317	CcSEcCtD
Pramipexole—HTR2B—adrenal gland—hypothyroidism	0.00229	0.0167	CbGeAlD
Pramipexole—HTR2B—blood—hypothyroidism	0.00229	0.0167	CbGeAlD
Pramipexole—Dehydration—Liotrix—hypothyroidism	0.00227	0.00311	CcSEcCtD
Pramipexole—Hypokalaemia—Liotrix—hypothyroidism	0.00223	0.00305	CcSEcCtD
Pramipexole—HTR2B—thyroid gland—hypothyroidism	0.00221	0.0161	CbGeAlD
Pramipexole—Muscular weakness—Liotrix—hypothyroidism	0.00216	0.00295	CcSEcCtD
Pramipexole—Flushing—Dextrothyroxine—hypothyroidism	0.00214	0.00292	CcSEcCtD
Pramipexole—Flushing—Levothyroxine—hypothyroidism	0.00214	0.00292	CcSEcCtD
Pramipexole—Abdominal distension—Liotrix—hypothyroidism	0.00213	0.00291	CcSEcCtD
Pramipexole—Dysphagia—Liotrix—hypothyroidism	0.00211	0.00289	CcSEcCtD
Pramipexole—DRD2—pituitary gland—hypothyroidism	0.00208	0.0151	CbGeAlD
Pramipexole—Angina pectoris—Liotrix—hypothyroidism	0.00206	0.00282	CcSEcCtD
Pramipexole—HTR1A—adrenal gland—hypothyroidism	0.00206	0.015	CbGeAlD
Pramipexole—Bronchitis—Liotrix—hypothyroidism	0.00203	0.00278	CcSEcCtD
Pramipexole—Alopecia—Dextrothyroxine—hypothyroidism	0.00203	0.00278	CcSEcCtD
Pramipexole—Alopecia—Levothyroxine—hypothyroidism	0.00203	0.00278	CcSEcCtD
Pramipexole—ADRA2C—pituitary gland—hypothyroidism	0.00202	0.0147	CbGeAlD
Pramipexole—Tension—Dextrothyroxine—hypothyroidism	0.00197	0.00269	CcSEcCtD
Pramipexole—Tension—Levothyroxine—hypothyroidism	0.00197	0.00269	CcSEcCtD
Pramipexole—SLC22A1—liver—hypothyroidism	0.00195	0.0142	CbGeAlD
Pramipexole—Nervousness—Dextrothyroxine—hypothyroidism	0.00195	0.00266	CcSEcCtD
Pramipexole—Nervousness—Levothyroxine—hypothyroidism	0.00195	0.00266	CcSEcCtD
Pramipexole—ADRA2A—heart—hypothyroidism	0.00193	0.0141	CbGeAlD
Pramipexole—Weight decreased—Liotrix—hypothyroidism	0.00191	0.00262	CcSEcCtD
Pramipexole—Tremor—Levothyroxine—hypothyroidism	0.00188	0.00257	CcSEcCtD
Pramipexole—Tremor—Dextrothyroxine—hypothyroidism	0.00188	0.00257	CcSEcCtD
Pramipexole—Acute coronary syndrome—Liotrix—hypothyroidism	0.00186	0.00254	CcSEcCtD
Pramipexole—Renal failure—Liotrix—hypothyroidism	0.00185	0.00253	CcSEcCtD
Pramipexole—Myocardial infarction—Liotrix—hypothyroidism	0.00185	0.00253	CcSEcCtD
Pramipexole—Agitation—Levothyroxine—hypothyroidism	0.00184	0.00252	CcSEcCtD
Pramipexole—Agitation—Dextrothyroxine—hypothyroidism	0.00184	0.00252	CcSEcCtD
Pramipexole—Sweating—Liotrix—hypothyroidism	0.00181	0.00247	CcSEcCtD
Pramipexole—ADRA2C—adrenal gland—hypothyroidism	0.00181	0.0132	CbGeAlD
Pramipexole—ADRA2C—blood—hypothyroidism	0.00181	0.0132	CbGeAlD
Pramipexole—Palpitations—Dextrothyroxine—hypothyroidism	0.00177	0.00242	CcSEcCtD
Pramipexole—Palpitations—Levothyroxine—hypothyroidism	0.00177	0.00242	CcSEcCtD
Pramipexole—Convulsion—Levothyroxine—hypothyroidism	0.00174	0.00237	CcSEcCtD
Pramipexole—Convulsion—Dextrothyroxine—hypothyroidism	0.00174	0.00237	CcSEcCtD
Pramipexole—Arthralgia—Dextrothyroxine—hypothyroidism	0.0017	0.00233	CcSEcCtD
Pramipexole—Arthralgia—Levothyroxine—hypothyroidism	0.0017	0.00233	CcSEcCtD
Pramipexole—Anxiety—Dextrothyroxine—hypothyroidism	0.0017	0.00232	CcSEcCtD
Pramipexole—Anxiety—Levothyroxine—hypothyroidism	0.0017	0.00232	CcSEcCtD
Pramipexole—Hypoaesthesia—Liotrix—hypothyroidism	0.00168	0.0023	CcSEcCtD
Pramipexole—ADRA2C—female gonad—hypothyroidism	0.00168	0.0123	CbGeAlD
Pramipexole—ADRA2A—gonad—hypothyroidism	0.00165	0.012	CbGeAlD
Pramipexole—Confusional state—Dextrothyroxine—hypothyroidism	0.00165	0.00225	CcSEcCtD
Pramipexole—Confusional state—Levothyroxine—hypothyroidism	0.00165	0.00225	CcSEcCtD
Pramipexole—HTR2A—heart—hypothyroidism	0.00164	0.012	CbGeAlD
Pramipexole—ADRA2A—pituitary gland—hypothyroidism	0.00161	0.0118	CbGeAlD
Pramipexole—Shock—Dextrothyroxine—hypothyroidism	0.00161	0.0022	CcSEcCtD
Pramipexole—Shock—Levothyroxine—hypothyroidism	0.00161	0.0022	CcSEcCtD
Pramipexole—Tachycardia—Dextrothyroxine—hypothyroidism	0.0016	0.00218	CcSEcCtD
Pramipexole—Tachycardia—Levothyroxine—hypothyroidism	0.0016	0.00218	CcSEcCtD
Pramipexole—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00158	0.00216	CcSEcCtD
Pramipexole—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00158	0.00216	CcSEcCtD
Pramipexole—Flushing—Liotrix—hypothyroidism	0.00157	0.00215	CcSEcCtD
Pramipexole—HTR1A—cerebellum—hypothyroidism	0.00157	0.0114	CbGeAlD
Pramipexole—HTR2A—cardiovascular system—hypothyroidism	0.00155	0.0113	CbGeAlD
Pramipexole—DRD2—testis—hypothyroidism	0.00154	0.0112	CbGeAlD
Pramipexole—Alopecia—Liotrix—hypothyroidism	0.0015	0.00205	CcSEcCtD
Pramipexole—ADRA2C—testis—hypothyroidism	0.00149	0.0109	CbGeAlD
Pramipexole—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00149	0.00204	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00149	0.00204	CcSEcCtD
Pramipexole—Insomnia—Levothyroxine—hypothyroidism	0.00148	0.00202	CcSEcCtD
Pramipexole—Insomnia—Dextrothyroxine—hypothyroidism	0.00148	0.00202	CcSEcCtD
Pramipexole—Dyspnoea—Levothyroxine—hypothyroidism	0.00146	0.00199	CcSEcCtD
Pramipexole—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00146	0.00199	CcSEcCtD
Pramipexole—Flatulence—Liotrix—hypothyroidism	0.00145	0.00199	CcSEcCtD
Pramipexole—Tension—Liotrix—hypothyroidism	0.00145	0.00198	CcSEcCtD
Pramipexole—Dysgeusia—Liotrix—hypothyroidism	0.00144	0.00197	CcSEcCtD
Pramipexole—ADRA2A—adrenal gland—hypothyroidism	0.00144	0.0105	CbGeAlD
Pramipexole—ADRA2A—blood—hypothyroidism	0.00144	0.0105	CbGeAlD
Pramipexole—Nervousness—Liotrix—hypothyroidism	0.00143	0.00196	CcSEcCtD
Pramipexole—DRD2—cerebellum—hypothyroidism	0.00142	0.0103	CbGeAlD
Pramipexole—ADRA2C—liver—hypothyroidism	0.00141	0.0103	CbGeAlD
Pramipexole—Fatigue—Dextrothyroxine—hypothyroidism	0.00141	0.00193	CcSEcCtD
Pramipexole—Fatigue—Levothyroxine—hypothyroidism	0.00141	0.00193	CcSEcCtD
Pramipexole—HTR2A—gonad—hypothyroidism	0.00141	0.0102	CbGeAlD
Pramipexole—ADRA2A—thyroid gland—hypothyroidism	0.00139	0.0101	CbGeAlD
Pramipexole—Vision blurred—Liotrix—hypothyroidism	0.00139	0.0019	CcSEcCtD
Pramipexole—Tremor—Liotrix—hypothyroidism	0.00138	0.00189	CcSEcCtD
Pramipexole—ADRA2C—cerebellum—hypothyroidism	0.00138	0.01	CbGeAlD
Pramipexole—HTR2A—pituitary gland—hypothyroidism	0.00137	0.00999	CbGeAlD
Pramipexole—Agitation—Liotrix—hypothyroidism	0.00135	0.00185	CcSEcCtD
Pramipexole—Feeling abnormal—Levothyroxine—hypothyroidism	0.00135	0.00184	CcSEcCtD
Pramipexole—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00135	0.00184	CcSEcCtD
Pramipexole—ADRA2A—female gonad—hypothyroidism	0.00134	0.00979	CbGeAlD
Pramipexole—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00134	0.00183	CcSEcCtD
Pramipexole—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00134	0.00183	CcSEcCtD
Pramipexole—Syncope—Liotrix—hypothyroidism	0.00132	0.00181	CcSEcCtD
Pramipexole—Palpitations—Liotrix—hypothyroidism	0.0013	0.00178	CcSEcCtD
Pramipexole—Urticaria—Dextrothyroxine—hypothyroidism	0.0013	0.00178	CcSEcCtD
Pramipexole—Urticaria—Levothyroxine—hypothyroidism	0.0013	0.00178	CcSEcCtD
Pramipexole—Loss of consciousness—Liotrix—hypothyroidism	0.00129	0.00177	CcSEcCtD
Pramipexole—Body temperature increased—Levothyroxine—hypothyroidism	0.00129	0.00177	CcSEcCtD
Pramipexole—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00129	0.00177	CcSEcCtD
Pramipexole—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00129	0.00177	CcSEcCtD
Pramipexole—Abdominal pain—Levothyroxine—hypothyroidism	0.00129	0.00177	CcSEcCtD
Pramipexole—Convulsion—Liotrix—hypothyroidism	0.00128	0.00175	CcSEcCtD
Pramipexole—Hypertension—Liotrix—hypothyroidism	0.00127	0.00174	CcSEcCtD
Pramipexole—Arthralgia—Liotrix—hypothyroidism	0.00125	0.00172	CcSEcCtD
Pramipexole—Chest pain—Liotrix—hypothyroidism	0.00125	0.00172	CcSEcCtD
Pramipexole—Anxiety—Liotrix—hypothyroidism	0.00125	0.00171	CcSEcCtD
Pramipexole—HTR2A—adrenal gland—hypothyroidism	0.00122	0.00893	CbGeAlD
Pramipexole—HTR2A—blood—hypothyroidism	0.00122	0.00892	CbGeAlD
Pramipexole—Confusional state—Liotrix—hypothyroidism	0.00121	0.00166	CcSEcCtD
Pramipexole—Oedema—Liotrix—hypothyroidism	0.0012	0.00164	CcSEcCtD
Pramipexole—Infection—Liotrix—hypothyroidism	0.00119	0.00163	CcSEcCtD
Pramipexole—ADRA2A—testis—hypothyroidism	0.00119	0.00868	CbGeAlD
Pramipexole—Shock—Liotrix—hypothyroidism	0.00118	0.00162	CcSEcCtD
Pramipexole—Tachycardia—Liotrix—hypothyroidism	0.00117	0.0016	CcSEcCtD
Pramipexole—Asthenia—Dextrothyroxine—hypothyroidism	0.00117	0.0016	CcSEcCtD
Pramipexole—Asthenia—Levothyroxine—hypothyroidism	0.00117	0.0016	CcSEcCtD
Pramipexole—Hyperhidrosis—Liotrix—hypothyroidism	0.00116	0.00159	CcSEcCtD
Pramipexole—Pruritus—Levothyroxine—hypothyroidism	0.00116	0.00158	CcSEcCtD
Pramipexole—Pruritus—Dextrothyroxine—hypothyroidism	0.00116	0.00158	CcSEcCtD
Pramipexole—Anorexia—Liotrix—hypothyroidism	0.00115	0.00157	CcSEcCtD
Pramipexole—Hypotension—Liotrix—hypothyroidism	0.00112	0.00154	CcSEcCtD
Pramipexole—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00112	0.00153	CcSEcCtD
Pramipexole—Diarrhoea—Levothyroxine—hypothyroidism	0.00112	0.00153	CcSEcCtD
Pramipexole—ADRA2A—cerebellum—hypothyroidism	0.0011	0.00802	CbGeAlD
Pramipexole—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.0011	0.0015	CcSEcCtD
Pramipexole—Insomnia—Liotrix—hypothyroidism	0.00109	0.00149	CcSEcCtD
Pramipexole—Paraesthesia—Liotrix—hypothyroidism	0.00108	0.00148	CcSEcCtD
Pramipexole—Dyspnoea—Liotrix—hypothyroidism	0.00107	0.00147	CcSEcCtD
Pramipexole—Decreased appetite—Liotrix—hypothyroidism	0.00105	0.00143	CcSEcCtD
Pramipexole—Vomiting—Dextrothyroxine—hypothyroidism	0.00104	0.00142	CcSEcCtD
Pramipexole—Vomiting—Levothyroxine—hypothyroidism	0.00104	0.00142	CcSEcCtD
Pramipexole—Fatigue—Liotrix—hypothyroidism	0.00104	0.00142	CcSEcCtD
Pramipexole—Rash—Levothyroxine—hypothyroidism	0.00103	0.00141	CcSEcCtD
Pramipexole—Rash—Dextrothyroxine—hypothyroidism	0.00103	0.00141	CcSEcCtD
Pramipexole—Dermatitis—Dextrothyroxine—hypothyroidism	0.00103	0.00141	CcSEcCtD
Pramipexole—Dermatitis—Levothyroxine—hypothyroidism	0.00103	0.00141	CcSEcCtD
Pramipexole—Constipation—Liotrix—hypothyroidism	0.00103	0.00141	CcSEcCtD
Pramipexole—Headache—Levothyroxine—hypothyroidism	0.00102	0.0014	CcSEcCtD
Pramipexole—Headache—Dextrothyroxine—hypothyroidism	0.00102	0.0014	CcSEcCtD
Pramipexole—HTR2A—testis—hypothyroidism	0.00101	0.00738	CbGeAlD
Pramipexole—Feeling abnormal—Liotrix—hypothyroidism	0.000991	0.00136	CcSEcCtD
Pramipexole—Gastrointestinal pain—Liotrix—hypothyroidism	0.000983	0.00134	CcSEcCtD
Pramipexole—Nausea—Dextrothyroxine—hypothyroidism	0.000971	0.00133	CcSEcCtD
Pramipexole—Nausea—Levothyroxine—hypothyroidism	0.000971	0.00133	CcSEcCtD
Pramipexole—HTR2A—liver—hypothyroidism	0.000958	0.00698	CbGeAlD
Pramipexole—Urticaria—Liotrix—hypothyroidism	0.000955	0.00131	CcSEcCtD
Pramipexole—Abdominal pain—Liotrix—hypothyroidism	0.00095	0.0013	CcSEcCtD
Pramipexole—Body temperature increased—Liotrix—hypothyroidism	0.00095	0.0013	CcSEcCtD
Pramipexole—HTR2A—cerebellum—hypothyroidism	0.000936	0.00682	CbGeAlD
Pramipexole—Hypersensitivity—Liotrix—hypothyroidism	0.000886	0.00121	CcSEcCtD
Pramipexole—Asthenia—Liotrix—hypothyroidism	0.000863	0.00118	CcSEcCtD
Pramipexole—Pruritus—Liotrix—hypothyroidism	0.000851	0.00116	CcSEcCtD
Pramipexole—Diarrhoea—Liotrix—hypothyroidism	0.000823	0.00113	CcSEcCtD
Pramipexole—Dizziness—Liotrix—hypothyroidism	0.000795	0.00109	CcSEcCtD
Pramipexole—Vomiting—Liotrix—hypothyroidism	0.000764	0.00105	CcSEcCtD
Pramipexole—Rash—Liotrix—hypothyroidism	0.000758	0.00104	CcSEcCtD
Pramipexole—Dermatitis—Liotrix—hypothyroidism	0.000757	0.00104	CcSEcCtD
Pramipexole—Headache—Liotrix—hypothyroidism	0.000753	0.00103	CcSEcCtD
Pramipexole—Nausea—Liotrix—hypothyroidism	0.000714	0.000977	CcSEcCtD
Pramipexole—SLC22A2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000123	0.000936	CbGpPWpGaD
Pramipexole—HTR1B—GPCR downstream signaling—VAV3—hypothyroidism	0.000123	0.000936	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—TRH—hypothyroidism	0.000123	0.000934	CbGpPWpGaD
Pramipexole—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000123	0.000932	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CLTC—hypothyroidism	0.000123	0.000932	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—TSHB—hypothyroidism	0.000122	0.00093	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—TSHR—hypothyroidism	0.000122	0.00093	CbGpPWpGaD
Pramipexole—DRD3—GPCR ligand binding—POMC—hypothyroidism	0.000122	0.000927	CbGpPWpGaD
Pramipexole—DRD4—GPCR downstream signaling—VAV3—hypothyroidism	0.000121	0.000921	CbGpPWpGaD
Pramipexole—HTR1D—GPCR downstream signaling—AVP—hypothyroidism	0.000121	0.000921	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TRH—hypothyroidism	0.000121	0.000921	CbGpPWpGaD
Pramipexole—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000121	0.000917	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—TSHB—hypothyroidism	0.000121	0.000916	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—TSHR—hypothyroidism	0.000121	0.000916	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—TSHB—hypothyroidism	0.00012	0.000915	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—TSHR—hypothyroidism	0.00012	0.000915	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TRH—hypothyroidism	0.000119	0.000907	CbGpPWpGaD
Pramipexole—HTR1B—GPCR downstream signaling—AVP—hypothyroidism	0.000119	0.000902	CbGpPWpGaD
Pramipexole—DRD4—GPCR downstream signaling—AVP—hypothyroidism	0.000117	0.000888	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—VAV3—hypothyroidism	0.000117	0.000887	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—VAV3—hypothyroidism	0.000116	0.00088	CbGpPWpGaD
Pramipexole—SLC22A1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000115	0.000873	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—VAV3—hypothyroidism	0.000114	0.000868	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TRH—hypothyroidism	0.000114	0.000865	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—VAV3—hypothyroidism	0.000112	0.00085	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—AVP—hypothyroidism	0.000112	0.000847	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CLTC—hypothyroidism	0.000111	0.000841	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TSHB—hypothyroidism	0.00011	0.000839	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TSHR—hypothyroidism	0.00011	0.000839	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR ligand binding—POMC—hypothyroidism	0.00011	0.000837	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—VAV3—hypothyroidism	0.00011	0.000837	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—AVP—hypothyroidism	0.00011	0.000837	CbGpPWpGaD
Pramipexole—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00011	0.000834	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—TSHB—hypothyroidism	0.00011	0.000832	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—TSHR—hypothyroidism	0.00011	0.000832	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—VAV3—hypothyroidism	0.000109	0.000829	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TSHB—hypothyroidism	0.000108	0.000821	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TSHR—hypothyroidism	0.000108	0.000821	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—AVP—hypothyroidism	0.000108	0.000819	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—VAV3—hypothyroidism	0.000108	0.000818	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TRH—hypothyroidism	0.000107	0.000816	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CLTC—hypothyroidism	0.000107	0.000812	CbGpPWpGaD
Pramipexole—HTR1A—GPCR ligand binding—POMC—hypothyroidism	0.000106	0.000808	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TSHB—hypothyroidism	0.000106	0.000808	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TSHR—hypothyroidism	0.000106	0.000808	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CLTC—hypothyroidism	0.000106	0.000808	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—AVP—hypothyroidism	0.000106	0.000806	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TRH—hypothyroidism	0.000106	0.000805	CbGpPWpGaD
Pramipexole—HTR2C—GPCR ligand binding—POMC—hypothyroidism	0.000106	0.000804	CbGpPWpGaD
Pramipexole—DRD5—GPCR downstream signaling—POMC—hypothyroidism	0.000105	0.000799	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—AVP—hypothyroidism	0.000105	0.000799	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—VAV3—hypothyroidism	0.000105	0.000799	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—AVP—hypothyroidism	0.000104	0.000789	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CLTC—hypothyroidism	0.000103	0.000786	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR ligand binding—POMC—hypothyroidism	0.000103	0.000782	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TSHB—hypothyroidism	0.000102	0.000771	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TSHR—hypothyroidism	0.000102	0.000771	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—AVP—hypothyroidism	0.000101	0.00077	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—VAV3—hypothyroidism	9.92e-05	0.000753	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—SH2B3—hypothyroidism	9.84e-05	0.000747	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—TSHB—hypothyroidism	9.8e-05	0.000744	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—VAV3—hypothyroidism	9.79e-05	0.000743	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—VAV3—hypothyroidism	9.73e-05	0.000739	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—SH2B3—hypothyroidism	9.64e-05	0.000732	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TSHB—hypothyroidism	9.58e-05	0.000727	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TSHR—hypothyroidism	9.58e-05	0.000727	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TRH—hypothyroidism	9.57e-05	0.000727	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—POMC—hypothyroidism	9.56e-05	0.000726	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—AVP—hypothyroidism	9.56e-05	0.000726	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—PRL—hypothyroidism	9.53e-05	0.000724	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—TSHB—hypothyroidism	9.53e-05	0.000724	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—SH2B3—hypothyroidism	9.49e-05	0.00072	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—IGF1—hypothyroidism	9.48e-05	0.00072	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TSHB—hypothyroidism	9.45e-05	0.000718	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TSHR—hypothyroidism	9.45e-05	0.000718	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—AVP—hypothyroidism	9.43e-05	0.000716	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—VAV3—hypothyroidism	9.39e-05	0.000713	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CLTC—hypothyroidism	9.39e-05	0.000713	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—AVP—hypothyroidism	9.38e-05	0.000712	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—VAV3—hypothyroidism	9.35e-05	0.00071	CbGpPWpGaD
Pramipexole—DRD2—GPCR ligand binding—POMC—hypothyroidism	9.34e-05	0.00071	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TRH—hypothyroidism	9.24e-05	0.000702	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CLTC—hypothyroidism	9.24e-05	0.000701	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TRH—hypothyroidism	9.2e-05	0.000698	CbGpPWpGaD
Pramipexole—HTR2A—GPCR ligand binding—POMC—hypothyroidism	9.19e-05	0.000698	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—TSHB—hypothyroidism	9.14e-05	0.000694	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—VAV3—hypothyroidism	9.09e-05	0.00069	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—SH2B3—hypothyroidism	9.05e-05	0.000687	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—AVP—hypothyroidism	9.05e-05	0.000687	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—AVP—hypothyroidism	9e-05	0.000684	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TRH—hypothyroidism	8.94e-05	0.000679	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—IGF1—hypothyroidism	8.86e-05	0.000673	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—VAV3—hypothyroidism	8.84e-05	0.000671	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—VAV3—hypothyroidism	8.82e-05	0.00067	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—AVP—hypothyroidism	8.76e-05	0.000665	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—PIK3C2A—hypothyroidism	8.74e-05	0.000663	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—SH2B3—hypothyroidism	8.54e-05	0.000648	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TSHR—hypothyroidism	8.53e-05	0.000648	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TSHB—hypothyroidism	8.53e-05	0.000648	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—VAV3—hypothyroidism	8.53e-05	0.000648	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—AVP—hypothyroidism	8.51e-05	0.000646	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—AVP—hypothyroidism	8.5e-05	0.000645	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—PIK3C2A—hypothyroidism	8.5e-05	0.000645	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—VAV3—hypothyroidism	8.49e-05	0.000644	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—SH2B3—hypothyroidism	8.43e-05	0.00064	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CLTC—hypothyroidism	8.41e-05	0.000638	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR ligand binding—POMC—hypothyroidism	8.37e-05	0.000635	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—VAV3—hypothyroidism	8.25e-05	0.000627	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—VAV3—hypothyroidism	8.25e-05	0.000626	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TSHB—hypothyroidism	8.24e-05	0.000626	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TSHR—hypothyroidism	8.24e-05	0.000626	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—AVP—hypothyroidism	8.22e-05	0.000624	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TSHB—hypothyroidism	8.2e-05	0.000622	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TSHR—hypothyroidism	8.2e-05	0.000622	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—AVP—hypothyroidism	8.18e-05	0.000621	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—PIK3C2A—hypothyroidism	8.14e-05	0.000618	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—VAV3—hypothyroidism	8.12e-05	0.000616	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TRH—hypothyroidism	8.12e-05	0.000616	CbGpPWpGaD
Pramipexole—HTR1D—GPCR downstream signaling—POMC—hypothyroidism	8.06e-05	0.000612	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TRH—hypothyroidism	7.98e-05	0.000606	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TSHB—hypothyroidism	7.97e-05	0.000605	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TSHR—hypothyroidism	7.97e-05	0.000605	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—AVP—hypothyroidism	7.95e-05	0.000604	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—AVP—hypothyroidism	7.95e-05	0.000603	CbGpPWpGaD
Pramipexole—HTR1B—GPCR downstream signaling—POMC—hypothyroidism	7.9e-05	0.000599	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—AVP—hypothyroidism	7.82e-05	0.000594	CbGpPWpGaD
Pramipexole—DRD4—GPCR downstream signaling—POMC—hypothyroidism	7.77e-05	0.00059	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—TSHB—hypothyroidism	7.74e-05	0.000588	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—SH2B3—hypothyroidism	7.61e-05	0.000578	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—VAV3—hypothyroidism	7.49e-05	0.000569	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—POMC—hypothyroidism	7.42e-05	0.000563	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—VAV3—hypothyroidism	7.38e-05	0.000561	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—VAV3—hypothyroidism	7.37e-05	0.00056	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—SH2B3—hypothyroidism	7.34e-05	0.000558	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—SLC5A5—hypothyroidism	7.34e-05	0.000557	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—POMC—hypothyroidism	7.32e-05	0.000556	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—SH2B3—hypothyroidism	7.3e-05	0.000555	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—PRL—hypothyroidism	7.3e-05	0.000555	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TRH—hypothyroidism	7.26e-05	0.000552	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TSHB—hypothyroidism	7.23e-05	0.000549	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TSHR—hypothyroidism	7.23e-05	0.000549	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—AVP—hypothyroidism	7.22e-05	0.000548	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—IGF1—hypothyroidism	7.2e-05	0.000546	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—POMC—hypothyroidism	7.17e-05	0.000544	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—PRL—hypothyroidism	7.15e-05	0.000543	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—SLC5A5—hypothyroidism	7.14e-05	0.000542	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TSHB—hypothyroidism	7.12e-05	0.00054	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TSHR—hypothyroidism	7.12e-05	0.00054	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—AVP—hypothyroidism	7.11e-05	0.00054	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—SH2B3—hypothyroidism	7.11e-05	0.000539	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—AVP—hypothyroidism	7.1e-05	0.000539	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—POMC—hypothyroidism	7.06e-05	0.000536	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—PRL—hypothyroidism	7.04e-05	0.000534	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—POMC—hypothyroidism	6.99e-05	0.000531	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PIK3C2A—hypothyroidism	6.9e-05	0.000524	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—POMC—hypothyroidism	6.9e-05	0.000524	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—SLC5A5—hypothyroidism	6.84e-05	0.000519	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—VAV3—hypothyroidism	6.76e-05	0.000513	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—POMC—hypothyroidism	6.74e-05	0.000511	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—PRL—hypothyroidism	6.72e-05	0.00051	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—VAV3—hypothyroidism	6.7e-05	0.000509	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—VAV3—hypothyroidism	6.62e-05	0.000502	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—VAV3—hypothyroidism	6.51e-05	0.000494	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—AVP—hypothyroidism	6.51e-05	0.000494	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TSHB—hypothyroidism	6.47e-05	0.000492	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TSHR—hypothyroidism	6.47e-05	0.000492	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—AVP—hypothyroidism	6.46e-05	0.00049	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—SH2B3—hypothyroidism	6.45e-05	0.000489	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—AVP—hypothyroidism	6.37e-05	0.000484	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—POMC—hypothyroidism	6.35e-05	0.000482	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—SH2B3—hypothyroidism	6.34e-05	0.000482	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—PRL—hypothyroidism	6.33e-05	0.000481	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—AVP—hypothyroidism	6.27e-05	0.000476	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—POMC—hypothyroidism	6.27e-05	0.000476	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—PRL—hypothyroidism	6.25e-05	0.000475	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—POMC—hypothyroidism	6.23e-05	0.000473	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—VAV3—hypothyroidism	6.21e-05	0.000472	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—POMC—hypothyroidism	6.01e-05	0.000457	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—AVP—hypothyroidism	5.99e-05	0.000455	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—POMC—hypothyroidism	5.98e-05	0.000454	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—VAV3—hypothyroidism	5.86e-05	0.000445	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—POMC—hypothyroidism	5.82e-05	0.000442	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—SLC5A5—hypothyroidism	5.8e-05	0.00044	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—VAV3—hypothyroidism	5.78e-05	0.000439	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—SH2B3—hypothyroidism	5.77e-05	0.000438	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—POMC—hypothyroidism	5.66e-05	0.00043	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—POMC—hypothyroidism	5.65e-05	0.000429	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—AVP—hypothyroidism	5.65e-05	0.000429	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—PRL—hypothyroidism	5.64e-05	0.000428	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—AVP—hypothyroidism	5.57e-05	0.000423	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—POMC—hypothyroidism	5.46e-05	0.000415	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—PRL—hypothyroidism	5.45e-05	0.000414	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—POMC—hypothyroidism	5.43e-05	0.000413	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—IGF1—hypothyroidism	5.43e-05	0.000412	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—PRL—hypothyroidism	5.42e-05	0.000411	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—POMC—hypothyroidism	5.29e-05	0.000401	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—POMC—hypothyroidism	5.28e-05	0.000401	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—PRL—hypothyroidism	5.27e-05	0.0004	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—VAV3—hypothyroidism	5.22e-05	0.000396	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—POMC—hypothyroidism	5.2e-05	0.000395	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—VAV3—hypothyroidism	5.04e-05	0.000383	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—AVP—hypothyroidism	5.03e-05	0.000382	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—VAV3—hypothyroidism	5.01e-05	0.000381	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—VAV3—hypothyroidism	4.88e-05	0.00037	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—AVP—hypothyroidism	4.86e-05	0.000369	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—AVP—hypothyroidism	4.83e-05	0.000367	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—POMC—hypothyroidism	4.8e-05	0.000364	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—PRL—hypothyroidism	4.78e-05	0.000363	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—POMC—hypothyroidism	4.73e-05	0.000359	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—POMC—hypothyroidism	4.72e-05	0.000358	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—PRL—hypothyroidism	4.71e-05	0.000357	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—AVP—hypothyroidism	4.7e-05	0.000357	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—VAV3—hypothyroidism	4.42e-05	0.000336	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—VAV3—hypothyroidism	4.35e-05	0.000331	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—POMC—hypothyroidism	4.33e-05	0.000328	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—POMC—hypothyroidism	4.29e-05	0.000326	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PRL—hypothyroidism	4.28e-05	0.000325	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—AVP—hypothyroidism	4.26e-05	0.000324	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—POMC—hypothyroidism	4.24e-05	0.000322	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—AVP—hypothyroidism	4.19e-05	0.000318	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—POMC—hypothyroidism	4.17e-05	0.000316	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IGF1—hypothyroidism	4.16e-05	0.000316	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IGF1—hypothyroidism	4.07e-05	0.000309	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IGF1—hypothyroidism	4.01e-05	0.000304	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—POMC—hypothyroidism	3.98e-05	0.000302	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—VAV3—hypothyroidism	3.96e-05	0.000301	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—POMC—hypothyroidism	3.84e-05	0.000291	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IGF1—hypothyroidism	3.83e-05	0.000291	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—AVP—hypothyroidism	3.82e-05	0.00029	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—POMC—hypothyroidism	3.75e-05	0.000285	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—POMC—hypothyroidism	3.73e-05	0.000284	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—POMC—hypothyroidism	3.7e-05	0.000281	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IGF1—hypothyroidism	3.61e-05	0.000274	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—POMC—hypothyroidism	3.58e-05	0.000272	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IGF1—hypothyroidism	3.56e-05	0.00027	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—POMC—hypothyroidism	3.34e-05	0.000254	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—POMC—hypothyroidism	3.23e-05	0.000245	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IGF1—hypothyroidism	3.22e-05	0.000244	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—POMC—hypothyroidism	3.21e-05	0.000244	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—POMC—hypothyroidism	3.12e-05	0.000237	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IGF1—hypothyroidism	3.1e-05	0.000236	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IGF1—hypothyroidism	3.09e-05	0.000234	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—POMC—hypothyroidism	3.03e-05	0.00023	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IGF1—hypothyroidism	3e-05	0.000228	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—POMC—hypothyroidism	2.83e-05	0.000215	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—POMC—hypothyroidism	2.79e-05	0.000212	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IGF1—hypothyroidism	2.72e-05	0.000207	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IGF1—hypothyroidism	2.68e-05	0.000204	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—POMC—hypothyroidism	2.54e-05	0.000193	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IGF1—hypothyroidism	2.44e-05	0.000185	CbGpPWpGaD
